First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 3,000 shares, a drop of 44.4% from the January 15th total of 5,400 shares. Based on an average daily volume of […]
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) saw a large growth in short interest in November. As of November 15th, there was short interest totalling 300 shares, a growth of 200.0% from the October 31st total of 100 shares. Based on an average daily trading volume, of 6,700 shares, the days-to-cover ratio […]
Paragon Private Wealth Management LLC raised its position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Free Report) by 20.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,185 shares of the company’s stock after purchasing an additional 4,518 shares […]
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) declared a dividend on Thursday, September 21st, NASDAQ reports. Stockholders of record on Monday, September 25th will be given a dividend of 0.0725 per share on Friday, September 29th. The ex-dividend date is Friday, September 22nd. First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.9 % […]
LPL Financial LLC cut its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Rating) by 9.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 72,779 shares of the company’s stock after selling 7,430 shares during the period. LPL Financial […]